# A Long-term Safety Study of QMF149 in Japanese Participants With Asthma

> **NCT03100500** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 51 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** QMF149

## Key facts

- **NCT ID:** NCT03100500
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-25
- **Primary completion:** 2018-07-19
- **Final completion:** 2019-02-12
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2020-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03100500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03100500, "A Long-term Safety Study of QMF149 in Japanese Participants With Asthma". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03100500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*